Genetic tests for breast cancer risk often look for DNA flaws that haven’t been reliably linked to the disease, a new report found, casting doubt on diagnostics that examine dozens of genes to calculate a patient’s susceptibility. Heidi Rehm, associate professor of pathology at Brigham and Women’s Hospital, is mentioned.
Trending News
Search for Babesiosis Treatment Gets a New Map
New clues to help fight tick-borne disease
Can an AI ‘Co-Scientist’ Accelerate Cancer Research?
Nearly $7 million funds agentic AI tools to assist investigations into cancer’s most pressing…
First Large-Scale Study Shows How Doctors Use AI in Medicine
Which practitioners use artificial intelligence in the clinic, and what do they ask?